230 related articles for article (PubMed ID: 15283420)
1. Development of a virosome vaccine against avian metapneumovirus subtype C for protection in turkeys.
Kapczynski DR
Avian Dis; 2004; 48(2):332-43. PubMed ID: 15283420
[TBL] [Abstract][Full Text] [Related]
2. Mucosal vaccination with formalin-inactivated avian metapneumovirus subtype C does not protect turkeys following intranasal challenge.
Kapczynski DR; Perkins LL; Sellers HS
Avian Dis; 2008 Mar; 52(1):28-33. PubMed ID: 18459292
[TBL] [Abstract][Full Text] [Related]
3. Investigations on the protective role of passively transferred antibodies against avian metapneumovirus infection in turkeys.
Rubbenstroth D; Rautenschlein S
Avian Pathol; 2009 Dec; 38(6):427-36. PubMed ID: 19937531
[TBL] [Abstract][Full Text] [Related]
4. Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys.
Hu H; Roth JP; Estevez CN; Zsak L; Liu B; Yu Q
Vaccine; 2011 Nov; 29(47):8624-33. PubMed ID: 21925228
[TBL] [Abstract][Full Text] [Related]
5. Induction of local and systemic immune reactions following infection of turkeys with avian Metapneumovirus (aMPV) subtypes A and B.
Liman M; Rautenschlein S
Vet Immunol Immunopathol; 2007 Feb; 115(3-4):273-85. PubMed ID: 17207537
[TBL] [Abstract][Full Text] [Related]
6. A wild goose metapneumovirus containing a large attachment glycoprotein is avirulent but immunoprotective in domestic turkeys.
Bennett RS; LaRue R; Shaw D; Yu Q; Nagaraja KV; Halvorson DA; Njenga MK
J Virol; 2005 Dec; 79(23):14834-42. PubMed ID: 16282483
[TBL] [Abstract][Full Text] [Related]
7. Protection against avian metapneumovirus subtype C in turkeys immunized via the respiratory tract with inactivated virus.
Cha RM; Khatri M; Sharma JM
Vaccine; 2011 Jan; 29(3):459-65. PubMed ID: 21073989
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of commercial broiler chicks against avian metapneumovirus infection: a comparison of drinking-water, spray and oculo-oral delivery methods.
Ganapathy K; Bufton A; Pearson A; Lemiere S; Jones RC
Vaccine; 2010 May; 28(23):3944-8. PubMed ID: 20392431
[TBL] [Abstract][Full Text] [Related]
9. Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain.
Sun J; Wei Y; Rauf A; Zhang Y; Ma Y; Zhang X; Shilo K; Yu Q; Saif YM; Lu X; Yu L; Li J
J Virol; 2014 Nov; 88(21):12348-63. PubMed ID: 25122790
[TBL] [Abstract][Full Text] [Related]
10. A genetically engineered prime-boost vaccination strategy for oculonasal delivery with poly(D,L-lactic-co-glycolic acid) microparticles against infection of turkeys with avian Metapneumovirus.
Liman M; Peiser L; Zimmer G; Pröpsting M; Naim HY; Rautenschlein S
Vaccine; 2007 Nov; 25(46):7914-26. PubMed ID: 17920166
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic and immunogenic responses in turkeys following in ovo exposure to avian metapneumovirus subtype C.
Cha RM; Khatri M; Mutnal M; Sharma JM
Vet Immunol Immunopathol; 2011 Mar; 140(1-2):30-6. PubMed ID: 21146877
[TBL] [Abstract][Full Text] [Related]
12. Compromised T-cell immunity in turkeys may lead to an unpredictable avian metapneumovirus vaccine response and variable protection against challenge.
Rubbenstroth D; Rautenschlein S
Avian Pathol; 2010 Oct; 39(5):349-57. PubMed ID: 20954011
[TBL] [Abstract][Full Text] [Related]
13. Development of vaccine-induced immunity against TRT in turkeys depends remarkably on the level of maternal antibodies and the age of birds on the day of vaccination.
Smialek M; Pestka D; Tykalowski B; Stenzel T; Koncicki A
BMC Vet Res; 2015 Feb; 11():28. PubMed ID: 25889279
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of chicks with live attenuated subtype B avian metapneumovirus vaccines: protection against challenge and immune responses can be unrelated to vaccine dose.
Ganapathy K; Jones RC
Avian Dis; 2007 Sep; 51(3):733-7. PubMed ID: 17992934
[TBL] [Abstract][Full Text] [Related]
15. Protection in specific pathogen free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination.
Ganapathy K; Cox WJ; Gough RE; Cargill P; Montiel E; Jones RC
Avian Pathol; 2007 Aug; 36(4):313-7. PubMed ID: 17620178
[TBL] [Abstract][Full Text] [Related]
16. Immunization of turkeys with a DNA vaccine expressing either the F or N gene of avian metapneumovirus.
Kapczynski DR; Sellers HS
Avian Dis; 2003; 47(4):1376-83. PubMed ID: 14708985
[TBL] [Abstract][Full Text] [Related]
17. Onset of immunity following in ovo delivery of avian metapneumovirus vaccines.
Tarpey I; Huggins MB
Vet Microbiol; 2007 Sep; 124(1-2):134-9. PubMed ID: 17462834
[TBL] [Abstract][Full Text] [Related]
18. Italian field survey reveals a high diffusion of avian metapneumovirus subtype B in layers and weaknesses in the vaccination strategy applied.
Cecchinato M; Lupini C; Ricchizzi E; Falchieri M; Meini A; Jones RC; Catelli E
Avian Dis; 2012 Dec; 56(4):720-4. PubMed ID: 23397844
[TBL] [Abstract][Full Text] [Related]
19. Avian metapneumovirus excretion in vaccinated and non-vaccinated specified pathogen free laying chickens.
Hess M; Huggins MB; Mudzamiri R; Heincz U
Avian Pathol; 2004 Feb; 33(1):35-40. PubMed ID: 14681066
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of loss of attenuation and extended field persistence of a live avian metapneumovirus vaccine.
Catelli E; Cecchinato M; Savage CE; Jones RC; Naylor CJ
Vaccine; 2006 Oct; 24(42-43):6476-82. PubMed ID: 16901592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
